Embed Size (px)
Citation preview
Dear Colleague,
Below please find the Massachusetts Life Sciences Center's weekly event listings. Our special
section on BIO-related events is starting to fill out - please feel free to send me any events you
would like to see listed for next week.
New event titles since last week are in red. For the latest news visit our web site at
www.masslifesciences.com. Also, the Center is now on Twitter! See the link at the bottom of
this email to follow us on Twitter.
If you are receiving this email as a forward, you can sign up to receive these emails directly by
using the "Join Our Mailing List" button at the bottom of this message. Event sponsors are
welcome to email me event information. We accept event information up until 12:00 p.m. on
Thursday to appear in the weekly listings the following Monday.
-Angus
Angus G. McQuilken
Vice President for Communications
Massachusetts Life Sciences Center
Upcoming Application Deadlines:
No application deadlines are pending, however the Center has announced the opening of
applications for this year's Internship Challenge, the Center's flagship workforce development
program. Students, recent college graduates and companies that may want to participate are
encouraged to learn more here.
BIO International Convention:
The 2012 BIO International Convention will be held June 18-21 in Boston. Have you
registered to attend? You can learn more at http://convention.bio.org.
BioSpace will host the BIO Career Fair on Monday, June 18th in Boston at the Hynes
Convention Center. Free to job seekers. If you are interested in a recruiting booth, please
reserve early. http://www.biocareerfair.org/
Digital BIO Brochure Links:
2012 Highlights Brochure: featuring suggested itineraries, sponsors, super sessions, BIO
Exhibition overview, registration info, housing, schedule at a glance, and more
2012 Breakout Sessions: Supplement: featuring descriptions and times of all confirmed
sessions
2012 Partnering Supplement: featuring "How to partner successfully", map, testimonials, and
more
9th Annual Community College Day at BIO:
When: June 18, 2012 7:30 a.m.- 5:00 p.m.
Where: The Westin Waterfront Boston Hotel, 425 Summer Street, Boston, MA 02210
Registration: http://www.regonline.com/Register/Checkin.aspx?EventID=1061901
This ninth annual BIO-associated day-long event features perspectives on biotechnology
education, training and the workforce from community college educators and their industry
partners plus a time to network with colleagues.
Register online by credit card for the $150 fee per person. There will be no on site
registration. Price includes continental breakfast and delicious buffet lunch.
BioBriefing: Biotech for the Non- Scientist
When: June 17, 2012 from 9:00am- 4:30pm
Where: Westin Boston Waterfront Hotel, 425 Summer St, Boston, MA
Registration: Pre-registration is required. No registration day of class, no walk-
ins. http://biotechprimerinc.com/bio2012.php
Instructors: Emily Burke, Ph.D; tim Fawcett, Ph.D; Amy Howes, Ph.D; Collins Jones, Ph.D;
Karin Lucas, Ph.D; Ted McCluskey, MD, Ph.D; Kelly McDonald, Ph.D; Lisa A. Selbie, Ph.D;
Simon J. Tullock, MD; Marian Downing, RBP, CBSP; Patricia L. Larrabee, M.S.
BIO is providing convention attendees the opportunity to learn the basics of biotech the day
prior to the 2012 BIO International Convention in one of three classes: BioBriefing, Drug
Development Briefing and Diagnostics Briefing.
These affiliated classes will require a separate attendee registration and payment to be made
by the participants.
Questions? Contact Kerri Muir at 410-377-4429 ext. 22 or [email protected]
Massachusetts-related sessions at BIO:
Crossing Borders and Boundaries: Emerging Strategies to Promote International
Collaboration
When: Tuesday, June 19, 2012 from 2:00pm- 2:45pm
Where: Room Location: 254A
Learn more here: http://mybio.zerista.com/event/member/46433
RSVP Here: http://bio2012internationalcollaboration.eventbrite.com
Collaboration across borders is revolutionizing the process of innovation and
commercialization. Come learn new approaches to international collaboration and how it can
positively affect your region or your business. Panelists from leading biotech regions
(Massachuestts, North Carolina, Israel & Catalonia) will discuss their strategies for effective
international collaboration in biopharma R&D, manufacturing and investment.
Learning Objectives:
Describe emerging trends in international collaboration
Evaluate ideas for expanding international collaboration
Identify best practices for cross-cultural collaboration
Speakers:
Avi Hasson: Chairman, Ministry of Industry, Trade and Labor of Israel
Bill Bullock, Vice President for Bioscience Industrial Development, North
Carolina Biotechnology Center
Montserrat Vendrell, CEO, Biocat, BioRegion of Catalonia
Susan Windham- Bannister, President & CEO, Massachusetts Life Sciences Center
Moderator:
Jos Scheffelaar, CEO & Co-Founder, Launch in US Alliance
Orphan Disease Forum - Specialized Marketing & Sales: A Vision for Orphan and Targeted
Therapies
When: Wednesday, June 20, 8:30 am - 9:45 am
Where: Room #209 at the Boston Convention and Exhibition Center
Website: http://mybio.zerista.com/event/member/46585#speakers
Donna LaVoie will moderate a panel at the 2012 BIO International Convention titled,
"Specialized Marketing & Sales: A Vision for Orphan and Targeted Therapies." Biotech
companies have paved the way for specialized marketing approaches for orphan diseases
since the early 1990s. Some companies have developed life-changing therapies that truly
change disease states. Today, biotech/pharma leaders have jumped in. But can all
companies large and small find the focus for these orphan diseases and put the patient
first? What are the obstacles associated with creating a specialized marketing and sales
effort for orphan drugs? Gain critical understanding of how companies are employing
specialized marketing and sales approaches that are patient-centric.
Speakers on the panel include:
Kyle Brown Founder & CEO of Innolyst
Jayne Gershokowitz, Senior Director of Patient Advocacy & Public Policy of Amicus
Therapeutics
Mark Rothera, Global President of Aegerion Pharmaceuticals
Rogerio Vivaldi, SVP and Head of Rare Disease Business Unit of Genzyme
Using Systems Biology to "Fast-Track" Development and Approval of Novel
Therapeutics and Diagnostics
When: Thursday, June 21st, 2012, 10:00 am - 11:30 am.
Where: Boston Convention & Exhibition Center
Overview of Systems Biology and how its application can determine more precisely and
quickly which biomarkers are relevant to specific diseases for diagnosis or therapeutic
intervention. This approach can also determine subgroups or different genotypes within
these diseases in developing a diagnostic test that will determine whether a patient will
respond to a specific drug with minimal side effects.
Drugs can now be targeted for a specific set of patients resulting in higher efficacy. In
return, the FDA requirements for the number of patients required for the phase I-III trials
may be smaller, the cost and time for R&D will be reduced and the approval time will be
shorter.
Moderator: 1) Regina Au, MBA, MIM - Principal, Strategic Marketing Consultant at BioMarketing Insight
Speakers: 1) David E. Hill, PhD - Research Scientist in Cancer Biology and Associate Director of the
Center for Cancer Systems Biology (CCSB) at the Dana-Farber Cancer Institute (DFCI).
2) Glenn Miller, PhD - Vice President / Head of Personalized Medicine, Astra Zeneca
3) Steven Tregay, PhD - Founder, President, and CEO of Forma Therapeutics
4) FDA Speaker - TBD
For details on the session and speakers go to http://biomarketinginsight.com/Events.htm
AvaMed 2012: The MedTech Conference
In addition to BIO International, Massachusetts will host this year's AdvaMed convention
October 1-3 at the Boston Convention & Exhibition Center. Organizers expect 2,500+
attendees, coming from companies ranging in size from the multi-billon down to start-ups.
You can count on this being a terrific business development opportunity, because it brings
together the decision-makers from all the business channels under one roof. Last year, 34%
of the attendees had the title of vice president and above. Learn more here!
Featured Events:
Fourth Annual Progress Toward Winning the War on Cancer
When: May 3, 2012 from 1pm-7pm
Where: Merck Research Labratories Boston, 33 Avenue Louis Pasteur, Boston, MA
Guest Speakers:
Kenneth C. Anderson, MD- Kraft Family Professor of Medicine, Harvard Medical School
American Cancer Society Clinical Research Professor
Director, LeBow Institute for Myeloma Therapeutics
Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Carl Barrett, PhD- Vice President IMED Translational Science
AstraZeneca Pharmaceuticals, LP
Sriram Sathyanarayanan, PhD- Translational Oncology Lead, Merck Research Labratories
Pasi A. Janne, MD, PhD- Lowe Center for Thoracic Oncology
Associate Professor of Medicine Harvard Medical School
Scientific Director Belfer Institute for Applied Cancer Science
We hope you will be joining us for the Fourth Annual Progress Toward Winning the War on
Cancer symposium at Merck Research Laboratories Boston, presented by MassBio and the
American Cancer Society.
RSVP by April 23 to [email protected] or call 508-270-4885
For more information, visit: http://acs-ne.informz.net/acs-
ne/data/images/acs_mbc_2012_symposium_agenda.pdf
BIOMED Israel
When: May 21-23,2012
Where: Tel Aviv, Israel
BioMed Executive Delegation is only open to senior executives and investors in the life
sciences.
BioMed is a leading international conference covering the fast-growing innovation in the
biomedical, health care and life science fields. Joining the Executive Delegation will provide
an invaluable opportunity to develop business connections and opportunities in the global
biotech market and particularly in Israel. Delegation members will enjoy an exclusive and
complementary invitation to the following events that will take place throughout the week of
BioMed:
- A panel discussion on "Funding and Partnership Opportunities Available for Foreign
Companies"
- A by-invitation only reception sponsored by OrbiMed Advisors
- A breakfast hosted by the Tel Aviv Stock Exchange, followed by an opening bell ceremony,
with the participation of senior industry executives and investors
- A visit to bio-tech companies in the North of Israel, followed by a visit to Ramat David air
force base and briefings by F-16 pilots. This will take place on the Thursday immediately
following the converence, May 24, 2012.
For questions or additional information, contact Rebecca Weinberg
at [email protected] or at 212-499-5622.
Translational Medicine Symposium: The Journey to Personalized Medicine
When: Wednesday, May 23, 2012, 9:30 a.m.- 4:30 p.m.
Where: UK Trade & Investment, British Consulate-General, One Broadway, Cambridge MA
02142
Register: http://www.idbs.com/events/translational-medicine-symposium-2012/
Fee: Complimentary
The success of Personalized Medicine relies on the joint efforts of hospitals, payers,
academic medical centers, pharmaceutical and diagnostic organizations. Our latest forum for
informed debate and lively discussion will take an in-depth look at all your major informatics
and analytics issues in translational medicine and biomarker research. Topics will include,
integration of Clinical, Omics, Research and Biobank data, translational collaborations across
sites and industry groups, Next Generation Sequencing data management and analytics
challenges, and clinical decision support with Omics data.
Keynote speaker: Dr. Susan Windham-Bannister, President and CEO, Massachusetts
Life Sciences Center
John Quackenbush, Ph.D.
Professor of Computational Biology & Bioinformatics, Dana-Farber Cancer Institute
Xinwei She, Ph.D.
Senior Research Scientist, Biological and Translational Informatics, Merck
Hai Hu, Ph. D.
Deputy Chief Scientific Officer Sr. Director of Biomedical Informatics, Windber
Research Institute
Paul Denny-Gouldson, Ph. D.
VP of Translational Medicine, IDBS
Complimentary event, followed by a reception. For more information please email Aneta
Manningtonova: [email protected]
Massachusetts Life Sciences Innovation Day
When: May 30, 2012, 8:00 a.m.-7:00 p.m.
Where: Harvard Club of Boston, 374 Commonwealth Ave., Boston
Registration: http://www.mattcenter.org/malsi-day-2012/home.html
The 5th Massachusetts Life Sciences Innovation (MALSI) Day is the biggest day for life
sciences startups and innovation in the Commonwealth of Massachusetts. This is a high-
energy, hands-on event which brings together scientific leaders and business experts to
mingle with innovators, post-docs, professors, entrepreneurs, and venture capitalists.
The Burden of Proof: As scientific breakthroughs progress from the moment of discovery
through development to the market, inventors and developers have to show that the
technology works - they have to "Prove It!" Our conference this year will focus on how
and when you have to prove your technology and what investors, regulators and payors need
to understand the product's viability and efficacy.
Keynote Speaker: Harvey F. Lodish, Ph.D., Member, Whitehead Institute for Biomedical
Research, Professor of Biology and Professor of Bioengineering, Massachusetts Institute of
Technology
Panels and Open Discussions will include: Funding models
Panel of CEOs who have recently raised money
What does your data show - what is publishable vs. what is commercializable?
Proof of Concept Experiments
Getting other people to prove it for you
Killer experiments that Big Pharma want to see
How big is your market and does it really exist
3rd RNAi Research & Therapeutics Conference
When: May 30-31, 2012
Where: Hyatt Harborside Hotel, 101 Harborside Drive, Boston
Register: http://www.gtcbio.com/rnai
GTC is proud to present our 3rd RNAi Research & Therapeutics Conference, which will be
held May 30-31, 2012 at the Hyatt Harborside in Boston, MA. We will bring together industry
leaders from major pharmaceutical companies, cutting-edge biotech companies as well as top
researchers from academia and government to present innovative and relevant applications
of current RNAi technologies to continually improve efficacy and meaningful data output in
drug discovery and development.
Topics of discussion include:
RNAi Delivery Methods
Gene Activation and Silencing by Small RNAs
Target Discovery and Validation
Therapeutic, Diagnostics and Clinical Applications
MicroRNA and Diseases
ncRNAs, lncRNA
Sign up for the RNAi Research and Therapeutics conference today!
Boston Biotech CEO Conference 2012
When: June 11-12, 2012
Where: Mandarin Oriental Hotel, 776 Boylston Street, Boston
Register: http://bbbiotechconference.com/conference-agenda.php?id=11
(Please call reservations at the Mandarin Oriental Hotel today to book your accommodations.
Room Reservations: Telephone: +1 (617) 535 8880 or +1 (866) 526 6567)
Current co-hosts include: Rich Aldrich, Josh Boger, Tony Coles, Michelle Dipp, Samantha Du,
Doug Fambrough, Colin Goddard, Sylvie Gregoire, Tuan Ha-Ngoc, Peter Hecht, Mark Levin,
John Maraganore, Lonnie Moulder, Richard Pops, George Scangos, Henri Termeer, and
Christoph Westphal.
The Boston Biotech CEO Conference is an exclusive networking forum for industry CEOs
offering access to the key decision makers in the life sciences. Attendees will gain insights
from presentations and panels featuring CEOs from several of the world's leading
pharmaceutical and biotechnology companies, industry leaders in venture capital, strategic
consulting and private equity also participate each year. The CEO Conference offers
opportunities throughout the day to network one-on-one with the industry's top deal makers
- senior executives from biotech and pharma, leaders from Wall Street and venture
capitalists.
Prostate Cancer Awareness Day at the State House
When: June 28, 2012, 10:00 a.m.-2:00 p.m.
Where: Great Hall, Massachusetts State House
RSVP: [email protected]
Join us for the Annual Prostate Cancer Awareness Day
at the Massachusetts State House featuring key legislators, Boston City Councilors,
medicine and advocacy. Therese Murray, President of the State Senate and Robert DeLeo,
Speaker of the House will be Guests of Honor. US Senator Scott Brown (via video
conference) will be Keynote Speaker.
Participating Organizations: This event is organized by AdMeTech Foundation in cooperation
with American Cancer Society's New England Division, Massachusetts Life Sciences Center,
Massachusetts Prostate Cancer Coalition, Prostate Health Education Network, US Too
International and ZERO - The Project to End Prostate Cancer.
For More Information, RSVP & Sponsorship:
or call 617-523-3535. www.admetech.org
Biopharm America
When: September 19-21, 2012
Where: Westin Boston Waterfront
Registration: http://www.ebdgroup.com/bpa/registration/index.php
Boston will be the place to meet one-to-one with the executives doing the deals in the life
science industry. If partnering is part of your strategic plan, then BioPharm America is not to
be missed.
Other Upcoming Events: BioScience Academy at Boston University
Information Session Dates: April 19, May 3, May 24 from 3:00pm- 4:00pm
Math Entrance Test Dates: May 1, May 15, May 29 from 3:00pm-4:00pm
Where: Gilmore Building, 801 Albany St, Boston, MA
Registration: Registration is required for both information sessions and testing. To sign up,
email [email protected]; application deadline: July 18, 2012 at 3pm
Description:
- Biotechnology lab skills training
- Certificate in Applied Biotechnology
- 12 BU credits, tuition supported
- Two semesters (September- May):
Fall: Monday- Thursday, 9am-3pm
Spring: Full-time internship & one evening course
- Job search assistance
- Boston University medical Campus
BioScience Academy is part of the SCILS Initiative, which is funded by a $5million grant from
the US Department of Labor's Employment and Training Administration.
The Business of Invention: Patenting for Biotechs
When: May 2, 2012 from 7:30am- 9:30am
Where: Nutter McClennen & Fish LLP, Louis D. Brandeis Conference Center, 155 Seaport
Boulevard, Boston, MA
Registration: http://businessofinvention.eventbrite.com/
Presented by: Konstantin Linnik, Ph.D., J.D., Nutter McClennen & Fish LLP, formerly senior
counsel at Pfizer
Topics will include:
- How to identify and properly capture valuable inventions
- What to patent and what to keep as a trade secret
- How to properly maintain lab notebooks
- The keys to effective patent claim drafting
- How to work with a patent attorney on developing an effective patent strategy
- How to address competitors' IP and freedom to operate Implications of the new US patent
reform
If you have any questions, please email us at [email protected] or call 617-439-2985
Communicating with Medical Devices using M2M and mHealth Wireless Technologies
When: May 2, 2012 from 5:30pm- 8:00pm
Where: Foley Hoag Emerging Enterprise Center, 1000 Winter Street, North Building, Waltham,
MA
Registration: For additional information and to register
Speakers:
David Lee Scher, MD- Clinical Associate Professor of Medicine, Pennsylvania State
University College of Medicine
Robert Havasy- Project Specialist/ Operations Manager, Center for Connected Health at
Partners Healthcare
Jonathan Clark- Founder and CEO, Sine-Wave Technologies
The Bioscience Network Presents: The Money of Invention - Experimenting with the
Biotech Risk Capital Model
When: May 3, 2012 from 5:30pm- 9:00pm
Where: Broad Institute, 415 Main St., Cambridge, MA 02142, 617-714-7000
Register: http://themoneyofinvention.eventbrite.com/
Moderator: Bruce Booth, Partner, Life Sciences Group, Atlas Venture Panel: Daphne Zohar, Founder, Managing Partner, PureTech Ventures Jason Rhodes, Executive Vice President and Chief Business Officer, Epizyme Inc. Barrett Bready, President and Chief Executive Officer, Nabsys Inc. Vin Miles, Venture Partner, Abingworth, LLP The Biotech/Pharma industry is rapidly changing in an effort to meet the current demands from
the market, regulators, investors and economic pressures. Please join us for an interactive discussion as we draw on our panel's experience and look at case
studies of successes and failures in biopharma investments and identify the challenges, priorities
and the role of strategic partners and much more. Agenda: 5:30-6:30 p.m.: Cocktails, Hors d'ouvres and Networking 6:30-8:00 p.m.: Panel Discussion For more information on the event, contact Iva Toudjarska at [email protected]
The Bioscience Network (TBN)
TBN is a non-profit organization formed to provide individuals in the bioscience industry with
opportunities for networking and career development. TBN is the premier resource for
professionals in the bioscience industry focused solely for the biosciences professional.
WEST's 5th Annual Leadership Awards
When: Thursday, May 3, 2012, 6:00-9:30 p.m.
Where: Hotel Marlowe, 25 Edwin H. Land Boulevard, Cambridge, MA 02141
Register: http://www.westorg.org/2012-05-03-wests-leadership-awards-
events (Registration Fee: Call 310-996-9435 to receive 20% when you mention this email!
WEST's fifth-annual Leadership Awards Event and silent auction. This is our opportunity to
acknowledge women who have demonstrated extraordinary leadership in science and
technology.
This year's awardees: Ellen Zane, former President and CEO of Tufts Medical Center, serves
as the Chairperson of the Mass Hospital Association and a director at Parexel, Pam Reeve,
Former founder and CEO of Lightbridge, Chair of the Commonwealth Institute board, Lead
director American Towers, Leanna Caron, SVP and GM of Sanofis Aventis's Regenerative
Medicine Business, WEST Advisory board member, Canadian and Olympic figure skating
judge, Cynthia Gilbert, Technologist and patent attorney, Founder and CEO of Hyperion Law
Cost: Members- $85; Non-members- $125. Wine, hors d'oeuvres, and a three course meal
will be served.
MDG Medical Software SIG May 2012: Agile Development in FDA Regulated Software
When: May 3, 2012 from 5:30pm- 8:30pm
Where: Constant Contact, Reservoir Place, 1601 Trapelo Road, Waltham, MA
Registration: For additional information and to register
Speaker: Mike Attili- President, Amaxo, Inc.
Conventional wisdom holds that the FDA prefers to see medical device manufacturers use a
sequential, waterfall lifecycle for product and software development. The result has led many
companies to bend and twist the process they actually use so that it looks like a linear
process to their regulators. No one is fooled and these efforts mainly add overhead and
waste. More importantly, they do little to improve the safety and effectiveness of their
products.
A growing number of medical device companies are adopting, and adapting, agile principles
and practices for the development of regulated software; not just to improve efficiency, but
also safety and effectiveness. This session will explore how to apply agile principles in a way
that is consistent with FDA regulations and guidance; how agile and XP practices can be
used to reduce risk and improve safety; which practices need modification to support the
demands of safety critical software; and how these have been applied on real projects to
achieve compliance.
Activate Networks' 2012 Summit Meeting: Harness the Power of Social Networks
When: Tuesday, May 8, 2012
Where: Charles Hotel, 1 Bennett Street, Cambridge, MA 02138
Activate Networks proudly presents Summit 2012, the world's leading conference on
leveraging your physician's social networks to drive sales results, Tue., May 8, 2012 at the
Charles Hotel, in Cambridge, Mass. Join us as real leaders discuss how to uncover and
measure real world social networks and leverage social influence for sales targeting and
identifying influential physicians. Space is limited - reserve your seat now.
For more information, visit
http://www.activatenetworks.net/summit-2012
Polymers in Biomedicine Scientific Symposium
When: May 9, 2012 from 9:00am- 3:00pm
Where: Conte Building, Room 110/111, University of Massachusetts Amherst
Registration: http://www.pse.umass.edu/cumirp/events.html
Keynote Speakers:
Alan Russell, PhD of the McGowan Institute for Regenerative Medicine
Darrell Irvine, PhD, Massachusetts Institue of Technology, Bioengineering Dept
We are pleased to invite you to the "Polymers in Biomedicine" symposium, which is being
jointly sponsored the UMass Polymer Science and Engineering Department and PVLSI's
Center of Excellence in Apoptosis Research (CEAR). Research funded by the CEAR program
will be presented either in oral or poster format during this one day event.
MassMEDIC: Preparing for the Medical Device Excise Tax
When: May 16, 2012 from 8:00am- 10:30am
Where: Foley Hoag, LLP, 1000 Winter St, Waltham, MA 02451
Registration: Onsite: Members- $50 Nonmembers- $85 In less than a year, most medical devices sold in the US will be subject to a 2.3% excise tax. The
results of a recent MassMEDIC survey shows that an alarming 75% of medtech companies have
not yet established internal procedures to collect or pay this tax. This seminar will provide the
latest information on implementation regulations proposed by the Internal Revenue Service and
procedures companies can consider in advance of the tax's effective date- January 1, 2013. The
agenda will also include an updated on Congressional efforts to repeal the medical device excise
tax and how the Supreme Court's review of the Affordable Care Act could affect its
implementation.
MDG Networking Meeting
When: May 16, 2012 from 5:30pm- 8:00pm
Where: Rebecca's Cafe, 275 Grove Street, Auburndale, MA
Information to be posted.
WIS: Clinical Trials: Management and Execution
When: Wednesday, May 16, 2012 5:30- 9:00 PM
Where: Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, MA 02421
Registration: http://www.hbanet.org/chapters/boston, go to "Upcoming Events", the event title is
WIS: Clinical Trials: Management and Execution
Member rate: $40, Nonmember rate: $70, Onsite registration is allowed
Clinical trials are a critical part of the biopharmaceutical drug development process. After a brief
summary of Clinical Trials Part 1: From Benchtop to Regulatory Approval, this stand-alone Part
2 of a 2-part program will present the management and execution of clinical trials through the
testimony of expert panelists. You will follow the development path from the Clinical
Operations, Regulatory Affairs, Clinical Pharmacology, Pharmacovigilance and the Contract
Research Organization (CRO) point of view; we will explore the different perspectives embraced
and you will gain a thorough understanding of what managing and executing clinical trials
entails.
Tufts CSDD Executive Forum Roundtable
When: May 17, 2012 from 10:00am- 4:00pm
Where: Tufts CSDD, 75 Kneeland Street, Suite 1100, Boston, MA
Our May 17th roundtable, Academic-Industry Partnerships: Opportunities and Pitfalls, will
examine the growing trend of academic-industry partnerships. Whereas both sectors have a
common goal of improving healthcare by providing newer and better treatments for patients,
there are significant challenges in optimizing the value of these relationships. This roundtable
will assess the structure and function of existing academic-industry partnerships, and will
examine strategies for increasing partnership value.
To join us at the May 17th roundtable, and for more information about Tufts CSDD Executive
Forum membership, visit our website at:
http://csdd.tufts.edu/courses/executive_forum or contact [email protected]
US-India BioPharma & Healthcare Summit
When: Friday, May 11, 2012, 9:30 a.m.-7:30 p.m.
Where: President's Ballroom, Hyatt Regency, Cambridge, MA
Registration: www.usaindiachamber.org There is a $900 registration fee.
Join the USA-India Chamber of Commerce as they present its annual US-India BioPharma &
Healthcare Summit. Network with industry leaders, investors, academicians, and policy makers.
The program has the highest concentration of senior level global BioPharma executives, R&D
leaders, Academicians and VCs. Seats are limited and registration will go up as the seats fill.
Panel Discussions & Keynotes covering:
Drug Discovery and Collaborative Research
Oncology- Science, Research Trends, Investor Perspective and Market Opportunities
Industry-Academic Research Partnerships
Emerging Markets- Opportunities & Strategies
Funding Innovation, Cross Border Investments and M&A trends in the BioPharma &
Healthcare
Clinical Research, IP, Licensing and Regulatory Issues
R&D Models- Lessons learned for BioPharma
MF-3 Third Microfluidics Consortium
When: May 18, 2012 from 8:30am- 4:30pm
Where: Cambridge, MA
Registration: http://www.cfbi.com/index_files/mf34paymentpage.htm
The Third Microfluidics Consortium brings together current and future stakeholders from across
a wide range of backgrounds with a shared interest in facilitating the growth of the industry
through better understanding of the challenges, opportunities and choices which it faces.
We organize closed meetings for our members on both sides of the Atlantic where we seek to
promote our mission "to grow the market for microfluidics enabled products and services" by:
- Finding shared interest across the landscape of applications
- Championing modularity and standards where appropriate
- Engaging with key industry influencers
While doing a few deals along the way.
On this occasion as we expand into the USA we are reaching out to selected guests beyond our
membership seeking to engage them in our vision, projects and thinking.
For more information, visit: www.cfbi.com or contact Peter Hewkin [email protected]
++441223850173
Managing Career Progression: From Individual contributor to Manager and Beyond
When: May 21, 2012 from 5:30pm- 9:00pm
Where: Indenix Pharmaceuticals, 60 Hampshire St, Cambridge, MA
Registration: http://www.hbanet.org/chapters/boston go to "Upcoming Events", the event title is
"Managing Career Progression: From Individual Contributor to Manager and Beyond"
Onsite registration is allowed; Member rate- $40 Nonmember rate- $70
So you have been promoted to a managerial role; now what?! It can be difficult as a new
manager to find resources to help prepare you for what to expect in your new role. Even an
experienced manager continuously searches for resources and tips to become a more effective
manager, especially as their responsibilities, and those of their employees, increase. This
program will discuss the progression of individual contributors to managers and beyond,
including challenges and best practices. A panel of managers will share their journeys,
challenges they have faced and how they overcame them. A career development coach will
introduce the topic and guide the discussion through several key take away practices, which will
be useful for managers at all levels.
While there will be time for participants to ask questions, we encourage you to submit a question
or challenge you face prior to the event to help facilitate the discussion. Please send questions to
Omics Evolution Summit
When: May 29-31, 2012
Where: Hyatt Harborside Hotel, Boston, MA
George Church, Professor of Genetics and Director of the Center for computational Genetics at
Harvard Medical School will be giving a plenary keynote presentation entitled "The Personal
Genome Project- Open Access to Genome Sequences + Trait Data" at the Omics Evolution
Summit.
The Personal Genome Project enables open observation and critique of a large cohort "test-
driving" comprehensive participatory personalized medicine. Since 2004, George Church and
his team have helped push the cost of reading and writing DNA (and biological systems) down
by a million-fold (5-fold faster exponential than Moore's law) and enabled fully open-access
human Genome+ Environment= Trait (GET) data, stem cells, and clinical community curation/
interpretation tools (Evidence.PersonalGenomes.org).
Keynote Speakers:
Craig C. Mello, Ph.D., distinguished Professor of Molecular Medicine and Nobel Laureate, at the
University of Massachusetts Medical School and HHMI,
Steven Burrill, CEO of Burrill & Company
For more information, visit: http://www.gtcbio.com/newsletter/OMXI-w.htm
The 2012 ABFO National Conference
When: May 30, 2012, 1:30 PM
Where: Westin Copley Place, Boston
Register: http://www.abfointernational.org/conference.html
On May 30, 2012 at 1:30 p.m., Donna LaVoie will moderate a panel at The Association of
Bioscience Financial Officers 2012 National Conference in Boston. The panel, titled "Top 10
Burning PR/IR Issues Facing CFOs in Transformative Times" will address how biotechnology
companies have managed through recent change, and how CFOs should be prepared for the
future in overseeing the IR/PR function.
Participants on the panel include:
Monique Allaire, Director of Investor Relations for AVEO Pharmaceuticals
Bo Piela, Vice President of Corporate Communications for Genzyme
Maria Cantor, Vice President of Investor Relations for Ariad Pharmaceuticals
MDG Marketing & Sales SIG
When: May 30, 2012 from 5:30pm- 8:00pm
Where: Rebecca's Cafe, 275 Grove Street, Auburndale, MA
This exciting event will showcase the development of an actual go-to-market strategy by event
participants in real time. This viable, early stage life sciences company is positioned to transform
the clinical research and drug discovery industries with their cutting edge technology that has
been validated at Harvard, Tufts, and UMass laboratories. Initial product launch is scheduled for
Q1 2013.
This Interactive Strategic Assessment has been designed for professionals responsible for the
marketing and sales of life sciences, medical technology, and devices. Consultants, scientists,
engineers, and technicians working on device design and development; professionals involved in
manufacturing; product and product development managers; business development managers,
marketing managers, quality personnel, regulatory affairs professionals, investment and
acquisition specialists, and field service engineers will all benefit from this event.
The leadership of this local company has asked our Marketing and Sales Special Interest Group
for their professional expertise, which will be revealed during this event.
Have fun with us and work your marketing muscle to help your fellow medical company
executives get ready for a critical time as they prepare to take their product to market.
The Future of Human Longevity: Medical Advances, Lifestyle Adjustments
When: May 31, 2012
Where: Harvard School of Public Health, 677 Huntington Ave, Room FXB-G12, Boston, MA
Topics to be covered:
- Public health initiatives
- Diabetes and obesity
- Personalized medicine
- Novel therapeutics
For more information:
http://cgd.swissre.com/events/Future_of_human_longevity_medical_advances_lifestyle_adjustm
ents.html
Grenoble: EuroMedtech 2012
When: May 31- June 1, 2012
Where: Grenoble, France
Registration: http://www.ebdgroup.com/emt/registration/index.php
Join us to the 4th Annual International Medtech Partnering Conference in Grenoble,
France. You will meet executives from emerging medical technology companies, established
large medtech companies, venture capital, private equity, and institutional financial firms,
distributors and hospitals, and service related companies.
EuroMedtech™ is Europe's leading medical technology partnering conference, providing
collaboration opportunities to medtech decision makers and investors. EuroMedtech caters to
companies involved in all parts of the advanced medical technology industry, from those serving
mainline therapeutic categories such as orthopedics and cardiovascular, through diagnostics,
imaging and eHealth to those involved in platform technologies such as biomaterials and
regenerative medicine.
For more information, visit:
http://www.ebdgroup.com/emt/index.php
The MassDevice Big 100 Roundtable East When: July 10, 2012 at 4:00pm
Where: The Westin Waltham Boston, Waltham, MA
MassDevice, the premier online journal for the medical device industry, invites you to an
incredible evening of discovery: The MassDevice Big 100 Roundtable East. The Big 100 is a
conversation among leaders- an unforgettable exchange of insight, ideas and contacts with the
most prominent pioneers in our field.
For more information, visit: www.massdevicebig100east.evenbrite.com
TUFTS CSDD's Leadership for Drug Development Teams
When: July 10-11, 2012
Where: Nine Zero Hotel, 90 Tremont Street, Boston, MA 02108
Registration:http://csdd.tufts.edu/courses/leadership_course
Who should attend: Team leaders, program managers, functional directors and scientists form
across the industry looking to build leadership skills for cross-functional R&D.
This fast-paced two-day workshop brings together team leaders, program managers, functional
directors and scientists from across the industry to build leadership skills for cross-functional
R&D efforts. Created specifically for pharmaceutical professionals, this highly interactive, case-
based program teaches you how to lead multi-disciplinary teams to collaborate effectively in face
of the increasingly complex challenges of life science innovation.
Early-bird registration rates are available and space is limited to 35 seats. Contact Jonathan
Hsieh at [email protected] or 617-636-0840 for more information.
Tech, Drugs & Rock 'n Roll
When: Tuesday, July 24, 2012, 4:00-8:00 PM
Where: George Sherman Union, 775 Commonwealth Avenue, Boston, MA 02215
Registration: Begins in May; visit website for more information
Last year's Tech, Drugs & Rock 'n Roll was a great success- over 650 industry professionals,
entrepreneurs and BU community members attended and evening of food, drinks, music and
technology. Guests ate and networked to the music of Lou Pride as various BU Start-Ups
presented their elevator pitches.
Provost Morrison spoke about the bright future of technology at Boston University and presented
the Innovator of the Year Award to Professor Avi Spira, founder of Allegro Diagnostics.
This year's sponsors include Nixon Peabody LLP, Latham & Watkins LLP, and SANOFI.
If you are interested in sponsoring TDRR, please contact Susan Mulrean at [email protected] or
617-353-6300.
BIOPARTNERING LATIN AMERICA 2012: Innovation, Business and Globalization
When: September 11-13, 2012 REGISTER:
Where: Hotel Sofitel Copacabana, Rio de Janeiro, Brazil
Registration: www.techvision.com/bpl (registration opens on April 30)
BioPartnering Latin America™ is an event focused on showcasing innovation, establishing
strategic contacts, generating business through face-to-face meetings (scheduled through the
exclusive system biopartnering.com™) and promoting high level networking. With each
passing year, BPL has established itself as the fastest-growing event of its segment, always
bringing the greatest players in the market and showing, through lectures and discussions, the
main trends in the life sciences industry. The growth of the bio-economy in Latin America has
been lead by small and medium sized enterprises fueled by a confluence of government support,
world-class science and a blooming venture capital industry. The regions achievements in human
and animal health biotechnologies have attracted many investors and multinational
companies, leading to an increasing number of partnering deals in the past couple of years. In
light of this scenario, attending BioPartnering Latin America™ and using the
biopartnering.com™ system enables you and your company to connect with the global life
science leaders who are driving growth in the region.
Harvard University Office of Technology Development and Speid & Associates Presents:
Drug Development Boot Camp
When: November 14-15, 2012
Where: The Harvard Club, Boston, MA
These 2-5 days courses are taught on the MIT campus by MIT faculty / researchers and experts
from industry and academia.
Register Now - Space is Limited! -
www.drugstomarket.com/harvarddrugbootcamp/
MIT Professional Education Short Programs: 2012 Biotechnology / Pharmaceutical courses
for professionals
Offerings include:
Flow Chemistry: Continuous Synthesis and Purification of Pharmaceuticals and Fine Chemicals
- June 25-27, 2012
Formulation and Stabilization of Biotherapeutics - July 9-11, 2012
Controlled Release Technology: Polymeric Delivery Systems for Pharmaceuticals, Proteins, and
Other Agents - July 9-13, 2012
Nanomaterials for Biological and Pharmaceutical Technologies - July 16-20, 2012
Fermentation Technology - July 30- August 3, 2012
Downstream Processing - August 6-10, 2012
Full schedule & details:
http://web.mit.edu/professional/short-programs/courses_topic.html
US Mission on US-Latvian Business Cooperation Opportunities When: July 1-3, 2012
Where: Riga, Latvia
RSVP: April 30
Visit Latvia and explore the business opportunities that we can offer to help your company
succeed in the global marketplace and expand in the Northern Europe as well as in nearby
regions.
The program of the US Business Mission will include:
Meetings with the President and the prime Minister of Latvia
Meetings with the Minister of Foreign Affairs and Minister of Economics of Latvia
Discussion session with the US Ambassador to Latvia
Overview of business environment and investment and export opportunities to Latvia
Discussions on specific sectors and industries tailored to your interests
Site visits of existing US companies in Latvia
One-on-one meetings with government representatives and private investors
Pre-4th of July celebration hosted by the Embassy of the United States
Networking with US and Latvian business communities
Sightseeing and special programs for spouses/ families (upon request)
We will provide you with a full business program, and you'll also have time to take in the sights
and enjoy the bright quality of life Latvia has to offer.
The contact person for further details on the Mission is Mr. Rudolfs Bremanis, Economic
counselor of the Embassy of Latvia in Washington, DC ([email protected]; +1-202-
328-2840).
MassBioEd Course Schedule Announced:
The MassBio Education Foundation has announced their 2012 Courses. To see the
full schedule for the winter and fall and to register, visit
https://secure.massbioed.org/courses/index.php
